A systematic review on pharmacology of saffron and its active constituents

Journal of Medicinal Plants

Volumn 7, Issue 28, 2008, Pages

  Kianbakht, S ^a,b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b Kavosh Research Town   (Iran)

Author keywords

Crocetin; Crocin; Pharmacology; Saffron; Safranal

Indexed keywords

CROCETIN; CROCIN; CROCUS SATIVUS EXTRACT;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; EYE PROTECTION; GENOTOXICITY; HUMAN; IMMUNOMODULATION; INSULIN RESISTANCE; LEARNING; MEMORY; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; PHYTOTHERAPY; REVIEW; STOMACH ULCER; SYSTEMATIC REVIEW; TISSUE OXYGENATION;

CROCUS SATIVUS; IRIDACEAE;

EID: 62349104381     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Salehi Surmaghi MH. Medicinal plants and phytotherapy. The World of Nutrition Publications. Iran. 2006, pp: 207-10.
2. nd International Symposium on Saffron Biology and Technology. Mashhad-Iran. Oct. 28-30, 2006, pp: 127-32.
3. Verma SK and Bordia A. Antioxidant property of saffron in man. Ind. J. Med. Sci. 1998; 52 (5): 204-7.
4. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH and Khani M. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo controlled trial. Phytother. Res. 2005; 19 (2): 148-51.
5. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F and Miller LG. A comparative trial of Crocus sativus L. (saffron) and imipramine in mild to moderate depression. Focus Altern. Complement. Ther. 2005; 10 (1): 22-3.
6. Noorbala AA, Akhondzadeh S, Tahmacebipour N and Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J. Ethnopharmacol. 2005; 97: 281-4.
7. Kianbakht S and Ghazavi A. Evaluation of immunological and hematological effects of saffron in men. Ethnopharmacologia. 2005; 36: 78-83.
8. Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR and Akhondzadeh S. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: A double-blind, randomized and placebo-controlled trial. Int. J. Obst. Gyn. 2008; 115 (4): 515-9.
9. Liakopoulou-Kyriakides M and Kyriakidis DA. Crocus sativus biological active constituents. Studies Nat. Prod. Chem. 2002; 26 (7): 293-312.
10. Xi L, Qian Z, Du P and Fu J. Pharmacokinetic properties of crocin (crocetin digentibiose ester) following oral administration in rats. Phytomedicine. 2007; 14 (9): 633-6.
11. 1 (sigma-1) receptors. Planta Med. 2008; 74: 764-72.
12. Hensel A, Niehues M, Lechtenberg M, Quandt B, Schepmann D and Wunsch B. Analytical and functional aspects on saffron from Crocus sativus L.: development of quality control methods, species assortment and affinity to sigma-1 and NMDA receptors. Planta Med. 2006; 72: 1005.
13. Abe K, Sugiura M, Shoyama Y and Saito H. Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons. Brain Res. 1998; 787 (1): 132-8.
14. Hosseinzadeh H and Sadeghnia HR. Protective effect of safranal on pentylenetetrazole-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2007; 14 (4): 256-62.
15. 2-adrenoceptors of guinea pig tracheal chains. Phytomedicine. 2008; 15 (12): 1038-45.
16. th Iranian Congress of Physiology & Pharmacology. Mashad-Iran. Aug. 26-30, 2007, p: 186.
17. th Iranian Congress of Physiology & Pharmacology. Mashad-Iran. Aug. 26-30, 2007, p: 187.
18. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. 2005; 227: 20-5.
19. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK and Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007; 27: 357-62.
20. Das I, Chakrabarty RN and Das S. Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pac. J. Cancer Prev. 2004; 5(1): 70-6.
21. Abdullaev FI, Espinosa J and Aguirre J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect. Prev. 2004; 28: 426-32.
22. Tavakkol-Afshari J, Brook A and Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem. Toxicol. 2008; 46: 3443-7.
23. Assimopoulou AN, Sinakos Z and Papageorgiou. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res. 2005; 19: 997-1000.
24. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, Jia L, Yin HX and Chen C. Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: A relationship investigation between antioxidant activity and crocin contents. Food Chem. 2008; 109: 484-92.
25. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA and Polissiou MG. Crocetin, dimethylcrocetin and safranal bind human serum albumin: stability and antioxidative properties. J. Agric. Food Chem. 2007; 55 (3): 970-7
26. Paramonova LI, Revina AA and Lizunkov AF. Interaction of carotenoids with the superoxide anion radical in relation to their stabilizing effect during cryoconservation of sperm. Dolk. Vses. Akad. S.-Kh. Nauk im. V. I. Lenina. 1989; 11: 30-2. Chem. Abstr. 112: 52954q.
27. Premkumar K, Abraham SK, Santhiya ST and Ramesh A. Inhibitory effects of aqueous crude extract of saffron (Crocus sativus L.) on chemical-induced genotoxicity in mice. Asia Pacific J. Clin. Nut. 2003; 12 (4): 474-6.
28. Premkumar K, Kavitha S, Santhiya ST and Ramesh AR. Interactive effects of saffron with garlic and curcumin against cyclophosphamide induced genotoxicity in mice. Asia Pacific J. Clin. Nut. 2004; 13 (3): 292-4.
29. Hosseinzadeh H and Sadeghnia HR. Effect of safranal, a constituent of Crocus sativus (saffron), on methyl mefhanesulfonate (MMS)-induced DNA damage in mouse organs: An alkaline single-cell gel electrophoresis (comet) assay. DNA and Cell Biol. 2007; 26 (12): 841-6.
30. Premkumar K, Thirunavukkarasu C, Abraham SK, Santhiya ST and Ramesh A. Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Hum. Exp. Toxicol. 2006; 25: 79-84.
31. Premkumar K, Abraham SK, Santhiya ST, Gopinath PM and Ramesh A. Inhibition of genotoxicity by saffron (Crocus sativus L.) in mice. Drug and Chem. Toxicol. 2001; 24 (4): 421-8.
32. Premkumar K, Abraham SK, Santhiya ST and Ramesh A. Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytother. Res. 2003; 17 (6): 614-7.
33. Abe K, Sugiura M, Yamaguchi S, Shoyama Y and Saito H. Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo. Brain Res. 1999; 851: 287-9.
34. Abe K and Saito H. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother. Res. 2000; 14 (3): 149-52.
35. Zhang Y, Shoyama Y, Sugiura M and Saito H. Effects of Crocus sativus L. on the ethanol-induced impairment of passive avoidance performances in mice. Biol. Pharm. Bull. 1994; 17 (2): 217-21.
36. Hosseinzadeh H and Ziaei T. Effects of Crocus sativus stigma extract and its constituents, crocin and safranal on intact memory and scopolamine-induced learning deficits in rats performing the morris water maze task. J. Med. Plants. 2006; 5 (19): 40-50.
37. th Iranian Congress of Physiology & Pharmacology. Mashhad-Iran. Aug. 26-30, 2007, p: 45.
38. th Iranian Congress of Physiology & Pharmacology. Mashhad-Iran. Aug. 26-30,2007, p: 95.
39. Pitsikas N, Zisopoulou S, Tarantilis PA, Kanakis CD, Polissiou MG and Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats' memory. Behav. Brain Res. 2007; 183 (2): 141-6.
40. Pitsikas N and Sakellaridis N. Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav. Brain Res. 2006; 173 (1): 112-15.
41. Wang CJ, Shiow SJ and Lin JK. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin Bl in rats. Carcinogenesis. 1991; 12 (3): 459-62.
42. Hosseinzadeh H, Sadeghnia HR, Ziaee T and Danaee A. Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J. Pharm. Pharmaceut. Sci. 2005; 8 (3): 387-93.
43. Hosseinzadeh H, Modaghegh MH and Saffari Z. Crocus sativus L. (saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evid. Based Complement. Altern. Med. Oct. 2007: 1-8.
44. Saleem S, Ahmad M, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T and Islam F. Effect of saffron (Crocus sativus) on neurobehavioral and neurochemical changes in cerebral ischemia in rats. J. Med. Food. 2006; 9 (2): 246-53.
45. Hosseinzadeh H and Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J. Pharm. Pharmaceut. Sci. 2005; 8 (3): 394-9.
46. Zheng YQ, Liu JX, Wang JN and Xu L. Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res. 2007; 1138 (23): 86-94.
47. Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Nasrul Hoda M and Islam F. Neuroprotection by crocetin in a hemiparkinsonian rat model. Pharmacol. Biochem. Behav. 2005; 81 (4): 805-13.
48. Soeda S, Ochiai T, Paopong L, Tanaka H, Shoyama Y and Shimeno H. Crocin suppresses tumor necrosis factor-α-induced cell death of neuronally differentiated PC-12 cells. Life Sci. 2001; 69: 2887-98.
49. Ochiai T, Soeda S, Ohno S, Tanaka H, Shoyama Y and Shimeno H. Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis. Neurochem. Int. 2004; 44: 321-30.
50. Ochiai T, Shimeno H, Mishima KI, Iwasaki K, Fujiwara M, Tanaka H, Shoyama Y, Toda A, Eyanagi R and Soeda S. Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim. Biophys. Acta. 2007; 1770 (4): 578-84.
51. Ochiai T, Ohno S, Soeda S, Tanaka H, Shoyama Y and Shimeno H. Crocin prevents the death of rat pheochromocytoma (PC-12) cells by its antioxidant effects stronger than those of α-tocopherol. Neurosci. Lett. 2004; 362: 61-4.
52. Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S Cordopatis P, Margarity M and Lamari FN. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 2006; 54 (23): 8762-8.
53. Papandreou MA, Kanakis CD, Polissiou M, Efthimiopoulos S Cordopatis P, Margarity M and Lamari FN. Investigation of in vitro activities of Crocus sativus styles extract relevant to Alzheimer's disease. Planta Med. 2007; 73: 981.
54. Hosseinzadeh H and Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002; 2: 7-15.
55. th Iranian Congress of Physiology & Pharmacology. Mashad-Iran. Aug. 26-30, 2007, pp: 78-9.
56. Vahidi AR, Bashardost N and Akhondi H. The analgesic effect of saffron extract in rats as compared with morphine sulfate. Planta Med. 2007; 73: 995.
57. Hosseinzadeh H and Shariaty VM. Antinociceptive effect of safranal, a constituent of Crocus sativus (saffron), in mice. Pharmacologyonline. 2007; 2: 498-503.
58. Hosseinzadeh H and Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch. Iran. Med. 2002; 5 (1): 44-7.
59. Hosseinzadeh H and Talebzdeh F. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia. 2005; 76 (7-8): 722-4.
60. Hosseinzadeh H and Sadeghnia HR. Effect of safranal from Crocus sativus on extracellular hippocampal levels of glutamate and aspartate during kainic acid seizures in anesthetized rats. Planta Med. 2007; 73: 968.
61. Mobasher M, Sahraei H, Sadeghi-Rad B, Kamalinejad M and Shams J. Effects of the Crocus sativus extract on the acquisition and expression of morphine-induced conditioned place preference in mice. Scient. J. Rafsanjan University Med. Sci. 2006; 5: 143-50.
62. Sahraei H, Mohammadi M, Kamalinejad M, Shams J, Ghoshooni H and Noroozzadeh A. Effects of the Crocus sativus L. extract on the acquisition and expression of morphine-induced conditioned place preference in female mice. J. Med. Plants. 2008; 7 (25): 39-48.
63. Khakpour B, Rostampour M, Sahraei H, Kamalinejad M and shams J. Effects of the aqueous extract of Crocus sativus flower stigmata on the acquisition and expression of morphine induced motor sensitivity in male mice. Kowsar Med. J. 2008; 12 (4): 313-21.
64. Sahraei H, Shams J, Marjani S, Molavi S and Kamalinejad M. Effects of the Crocus sativus L. extract on the acquisition and expression of morphine-induced behavioral sensitization in female mice. J. Med. Plants. 2007; 6 (21): 26-35.
65. Karimi Gh, Hosseinzadeh H and Khaleghpanah P. Study of antidepressant effect of aqueous and ethanolic extract of Crocus sativus in mice. Iranian J. Basic Med. Sci. 2001; 4 (3): 11-5.
66. Hosseinzadeh H, Karimi Gh and Niapoor M. Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. J. Med. Plants. 2004; 3 (11): 48-58.
67. Hosseinzadeh H, Motamedshariaty V and Hadizadeh F. Antidepressant effect of kaempferol, a constituent of saffron (Crocus sativus) petal, in mice and rats. Pharmacologyonline. 2007; 2: 367-70.
68. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S and Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006; 13 (9-10): 607-11.
69. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH and Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007; 31 (2): 439-42.
70. Jessie SW and Krishnakantha TP. Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron. Mol. Cell. Biochem. 2005; 278 (1-2): 59-63.
71. Gainer JL and Jones JR. The use of crocetin in experimental atherosclerosis. Experientia. 1975; 31: 548-9.
72. Sheng L, Qian Z, Zheng S and Xi L. Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. Eur. J. Pharmacol. 2006; 543 (1-3): 116-22.
73. Xi L, Qian Z, Shen X, Wen N and Zhang Y. Crocetin prevents dexamefhasone-induced insulin resistance in rats. Planta Med. 2005; 71: 917-22.
74. Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N, Sheng L, Shi Y and Zhang Y. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J. Nut. Biochem. 2007; 18: 64-72.
75. Zheng S, Qian Z, Sheng L and Wen N. Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation. J. Cardivasc. Pharmacol. 2006; 47: 70-6.
76. He SY, Qian ZY, Wen N, Tang FT, Xu GL and Zhou CH. Influence of crocetin on experimental atherosclerosis in hyperlipidemic-diet quails. Eur. J. Pharmacol. 2007; 554: 191-5.
77. Xu GL, Yu SQ, Gong ZN and Zhang SQ. Study of the effect of crocin on rat experimental hyperlipidemia and the underlying mechanisms. Zhongguo Zhong Yao Za Zhi. 2005; 30: 369-72.
78. Xiang M, Yang M, Zhou C, Liu J, Li W and Qian Z. Crocetin prevents AGEs-induced vascular endothelial cell apoptosis. Pharmacol. Res. 2006; 54: 268-74.
79. Xiang M, Qian ZY, Zhou CH, Liu J and Li WN. Crocetin inhibits leukocyte adherence to vascular endothelial cells induced by AGEs. J. Ethnopharmacol. 2006; 107: 25-31.
80. Grisolia S. Hypoxia, saffron and cardiovascular disease. Lancet. 1974; 2: 41-2.
81. Gainer JV. Use of crocetin in experimental spinal cord injury. J. Neurosurg. 1977; 46: 358-80.
82. Gainer JV and Nugent R. Effect of increasing the plasma oxygen diffusivity on experimental cryogenic edema. J. Neurosurg. 1976; 45: 535-8.
83. Diluccio RC and Gainer JL. Increasing alveolar oxygen transport. Aviat. Space Environ. Med. 1980; 51: 18-20.
84. Gainer JL, Rudolph DB and Caraway DL. The effect of crocetin on hemorrhagic shock in rats. Circ. Shock. 1993; 41: 1-7.
85. Seyde WC, McKernan DJ, Laudeman T, Gainer JL and Longnecker DE. Carotenoid compound crocetin improves cerebral oxygenation in hemorrhaged rats. J. Cereb. Blood Flow Metab. 1986; 6: 703-7.
86. Holloway GM and Gainer JL. The carotenoid crocetin enhances pulmonary oxygenation. J. Appl. Physiol. 1988; 65: 683-6.
87. Miller TL, Willett SL, Moss ME, Miller J and Belinka BA. Binding of crocetin to plasma albumin. J. Pharm. Sci. 1982; 71: 173-7.
88. 45Ca. Appl. Radiat. Isotopes. 2005; 63 (2): 151-5.
89. Yin MH, Kang DG, Choi DH, Kwon TO and Lee HS. Screening of vasorelaxant activity of some medicinal plants used in oriental medicines. J. Ethnopharmacol. 2005; 99 (1): 113-7.
90. Boskabady MH, Shafei MN, Shakiba A and Sang Sefidi H. Effect of aqueous-ethanol extract from Crocus sativus (saffron) on guinea-pig isolated heart. Phytother. Res. 2008; 22 (3): 330-4.
91. Khori V, Nayebpour M and Mansourian AR. The effect of aqueous extract of Crocus sativus on the electrophysiological properties of isolated perfused rabbit AV-node. Pakistan J. Biol. Sci. 2006; 9 (14): 2647-51.
92. Khori V, Nayebpour M, Rakhshan E and Mir Abbasi A. The role of nitric oxide synthase enzyme inhibitor on antiarrhythmic effects of Crocus sativus on isolated rabbit atrioventricular node. J. Gilan University Med. Sci. 2007; 16 (63): 1-10.
93. Boskabady MH and Aslani MR. Relaxant effect of Crocus sativus (saffron) on guinea pig tracheal chains and its possible mechanisms. J. Pharm. Pharmacol. 2006; 58 (10): 1385-90.
94. th Iranian Congress of Physiology & Pharmacology. Mashhad-Iran. Aug. 26-30, 2007, pp: 31-2.
95. Hosseinzadeh H and Ghenaat J. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia. 2006; 77 (6): 446-8.
96. Mann an A, Ubaidullah, Ahmad R and Khan RA. Therapeutic role of saffron and honey in pneumonia in children. Curr. Pediatr. Res. 2006; 10 (1-2): 25-7.
97. Al-Mofleh IA, Al-haider AA, Mossa JS, Al-Sohaibani MO, Qureshi S and Rafatullah S. Antigastric ulcer studies on 'saffron' Crocus sativus L. in rats. Pakistan J. Biol. Sci. 2006; 9 (6): 1009-13.
98. Kianbakht S and Mozaffari K. Effects of saffron and its active constituents, crocin and safranal, on prevention of indomethacin induced gastric ulcers in diabetic and nondiabetic rats. Proceedings of International Congress of Traditional and Complementary Medicine. Sari-Iran. Oct. 28-31, 2008, p: 117.
99. Yang XG, Zhang Q, Yu IN, Lian IP and Lei AJ. Effect of Crocus sativus extracti on the concentration of glutamic acid in the vitreous body in rabbits with chronic ocular hypertension. Int. J. Ophthalmol. 2006; 6 (5): 1025-6.
100. Yang XG, Sun DJ, Wang YW, Jin WL, Wang XJ and Duan XL. Effect of Crocus sativus on SOD and MDA alterations in the retina of rabbits with chronic ocular hypertension. Int. J. Ophthalmol. 2008; 8 (1): 47-9.
101. Maccarone R, Di Marco S and Bisti S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest. Ophthalmol. Visual Sci. 2008; 49 (3): 1254-61.
102. Xuan B, Zhou YH, Li N, Min ZD and Chiou GC. Effect of crocin analogs on ocular blood flow and retinal function. J. Ocul. Pharmacol. Ther. 1999; 15: 143-52.
103. rd National Symposium on Saffron. Mashhad-Iran. Dec. 2-3, 2003, pp: 239-44.
104. Talei GR, Meshkatalsadat MH and Mosavi Z. Antibacterial activity and chemical composition of essential oils from four medicinal plants of Lorestan, Iran. J. Med. Plants 2007; 6 (Suppl. 1): 45-52.
105. Li CY and Wu TS. Constituents of the stigmas of Crocus sativus and their tyrosinase inhibitory activity. J. Nat. Prod. 2002; 65: 1452-6.
106. Fatehi M, Rashidabady T and Fatehi-Hassanabad Z. Effects of Crocus sativus petals' extract on rat blood pressure and on responses induced by electrical field stimulation in the rat isolated vas deferens and guinea-pig ileum. J. Ethnopharmacol. 2003; 84: 199-203.
107. Hosseinzadeh H, Ziaee T and Sadeghi A. The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine. 2008; 15: 491-5.
108. Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA and Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine. 2008; 15 (12): 1135-9.
109. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp. Biol. Med. 2002; 247: 20-5.
110. Golalipour MJ, Gharravi AM, Ghafari S, Afshar M and Khori V. Effects of Crocus sativus on the fetal development of NMRI mice. Saudi Med. J. 2008; 29 (2): 309-11.
111. Martin G, Goh E and Neff AW. Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem. Toxicol. 2002; 40: 959-64.
112. Sadraei H, Ghannadi A and Takei-Bavani M. Effects of Zataria multiflora and Carum carvi essential oils and hydroalcoholic extracts of Passiflora incarnata, Berberis integerrima and Crocus sativus on rat isolated uterus. Int. J. Aromather. 2003; 13 (2-3): 121-7.
113. Chang PY, Wang CK, Liang CT and Kuo W. The pharmacological action of Zang Hong Hua (Crocus sativus). I. effects on the uterus and estrous cycle. Yao Hsueh Pao. 1964; 11; 94-100.
114. Wintherhalter P and Straubinger M. Saffron-renewed interest in an ancient spice. Food Rev. Int. 2000; 16 (1): 39-59.
115. nd International Symposium on Saffron Biology and Technology. Mashhad-Iran. Oct. 28-30, 2006, pp: 211-7.
116. Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O and Hosseinzadh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008; 15 (12): 1032-7.
117. Wuthrich B, Schmid-Grendelmeyer P and Lundberg M. Anaphylaxis to saffron. Allergy. 1997; 52: 476-7.
118. Lucas CD, Hallagan JB and Taylor SL. The role of natural color additives in food allergy. Adv. Food Nutr. Res. 2001; 43: 195-216.
119. Moneret-Vautrin DA, Morisset M, Lemerdy P, Croizier A and Kanny G. Food allergy and IgE sensitization caused by spices: CICBAA data (based on 589 cases of food allergy). Allerg. Immunol. 2002; 34: 135-40.
120. Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm. Acta Helv. 2000; 74: 211-8.
121. Hayashi T and Su TP. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs. 2004; 18 (5): 269-84.
122. Duncan G and Wang L. Focus on molecules: the sigma-1 receptor. Exp. Eye Res. 2005; 81: 121-2.
123. Perera CO and Yen GM. Functional properties of carotenoids in human health. Int. J. Food Properties. 2007; 10 (2): 201-30.